ScoreWhy is iSERA Lifesciences Ltd ?
1
Poor Management Efficiency with a low ROE of 0.79%
- The company has been able to generate a Return on Equity (avg) of 0.79% signifying low profitability per unit of shareholders funds
2
High Debt Company with a Debt to Equity ratio (avg) of 4.69 times
- High Debt Company with a Debt to Equity ratio (avg) of 4.69 times
- The company has been able to generate a Return on Equity (avg) of 0.79% signifying low profitability per unit of shareholders funds
3
Healthy long term growth as Net Sales has grown by an annual rate of 136.00% and Operating profit at 40.00%
4
Flat results in Jun 26
- PBDIT(Q) Lowest at Rs -0.34 cr.
- PBT LESS OI(Q) Lowest at Rs -0.34 cr.
5
With ROE of 3.2, it has a Very Expensive valuation with a 14.7 Price to Book Value
- Over the past year, while the stock has generated a return of 2343.12%, its profits have risen by 14%
6
Majority shareholders : Promoters
7
Market Beating Performance
- Even though the market (BSE500) has generated negative returns of -2.08% in the last 1 year, the stock has been able to generate 2343.12% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to iSERA Lifescienc should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is iSERA Lifescienc for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
iSERA Lifescienc
2343.12%
135.91
17.24%
Sensex
-8.86%
-0.66
13.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
136.00%
EBIT Growth (5y)
40.00%
EBIT to Interest (avg)
-0.02
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
1.46
Tax Ratio
23.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-3.45%
ROE (avg)
0.79%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
237
Industry P/E
31
Price to Book Value
14.67
EV to EBIT
119.80
EV to EBITDA
119.80
EV to Capital Employed
17.01
EV to Sales
88.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.83%
ROE (Latest)
3.15%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
PAT(Latest six months)
Higher at Rs 0.21 cr
-2What is not working for the Company
PBDIT(Q)
Lowest at Rs -0.34 cr.
PBT LESS OI(Q)
Lowest at Rs -0.34 cr.
Loading Valuation Snapshot...
Here's what is working for iSERA Lifescienc
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.21 cr
than preceding 12 month period ended Jun 2026 of Rs -0.06 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Here's what is not working for iSERA Lifescienc
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.34 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.34 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Footer loading
